Leptin, a recently discovered hormone secreted mainly from adipose tissue, was first described as a regulator of adiposity, food intake and energy metabolism. It is now apparent that leptin physiology is much more complex and is likely to play an important role in many other systems including reproduction, haematopoiesis and immunity. Leptin levels have been shown to be well correlated with body fat in both humans and rodents, with administration of exogenous leptin to rats and mice resulting in loss of body fat. Leptin is, therefore, likely to be an important humoral signal to the central nervous system on body composition and regulation of food consumption.
Introduction
Zhang and co-workers (1994) recently reported the discovery of leptin, a hormone secreted primarily by adipose tissue. This report, together with the identification of its receptor in the hypothalamus and other peripheral tissues (Tartaglia et al. 1995) , has provided important new information to help unravel some of the gaps in our current knowledge on the recognition of nutritional status. The leptin gene encodes a 4·5 kb mRNA (Zhang et al. 1994 ), which appears to be expressed primarily in adipose tissue and encodes a protein of approximately 16 kDa. There is no known close homology with leptin and other proteins but it is structurally similar to the long chain helical cytokine family (Zhang et al. 1997) , with the homology of the derived leptin amino acid sequence across the different species ranging from 95% to 67% (Zhang et al. 1997) . In the ob/ob strain of mice, a non-functional leptin gene results in the mutant mice having an increased food intake, reduced energy expenditure and elevated insulin and cortisol levels which result in obesity, sterility and noninsulin dependent diabetes mellitus (Friedman et al. 1991) . These effects can be reversed with the administration of exogenous leptin .
Although it has been shown that plasma leptin levels are highly correlated with body fat in humans (Considine et al. 1996 , Zimmet & Collier 1996 and rodents (Frederich et al. 1995 , the mechanisms which modulate leptin levels remain unclear. Insulin has been shown to stimulate leptin secretion by rat adipocytes both in vitro (Leroy et al. 1996) and in vivo (Hardie et al. 1996) . In humans, although correlations between leptin concentrations and insulin concentrations have been reported (Rosenbaum et al. 1996 , Widjaja et al. 1997 ), short-term insulin infusions fail to modify leptin mRNA expression, whereas in mice a single injection of insulin increases mRNA (Saladin et al. 1995 , Mizuno et al. 1996 . A single injection of glucose also results in elevation of leptin mRNA in mice (Mizuno et al. 1996) , while in humans, glucose does not appear to modulate leptin levels (Bauman et al. 1996) .
Recently, mRNA encoding leptin has been isolated in pig (Bidwell et al. 1997 , Ramsay et al. 1998 , sheep (Dyer et al. 1997) and cattle (Ji et al. 1998) adipose tissue. These studies showed that breed, stage of growth, feed intake and body fat were correlated with leptin mRNA expression. The majority of the current information on leptin, however, is restricted to work on rodents and studies of human obesity, partly due to the unavailability of suitable assays for leptin from other species.
The aim of this study was to develop an assay capable of measuring leptin in sheep and to investigate the effects of glucose and glucose modulating hormones on the shortterm regulation of plasma leptin concentrations in sheep.
Materials and Methods

Leptin peptides
An amino terminus peptide 6-14, VQDDTKTLIKT(C) and a carboxyl terminus peptide 124-135 (C)VALSR-LQGSLQD were selected, based on the bovine leptin sequence (Genbank accession U50365), and synthesised by Chiron Mimotopes (Clayton, Victoria, Australia).
Recombinant bovine leptin
Two oligonucleotide primers were synthesised based on the known genomic sequence of the bovine leptin gene (Genbank accession U50365). The first primer, a sense primer, corresponded to the 5 end of the mature protein sequence i.e. 5 -GTGCCCATCCGCAAGGTCC-3 . The second primer was a reverse sense primer based in the immediate 3 UTR following the stop codon i.e. 5 -TCAGCACCCGGGACTGAGG-3 . These primers were used to amplify DNA from bovine fat cDNA. The amplified DNA of approximately 440 bp corresponded to the mature form of bovine leptin (i.e. without the region coding for the signal sequence) as determined by sequencing both strands. This DNA was subcloned into the expression vector pQE9 (QIAGEN Pty Ltd, Cliffton Hill, Vic, Australia) and recombinant leptin containing an N-terminal hexaHis-affinity tag expressed in E. coli. The protein was affinity purified by nickel nitrilotriacetic acid (Ni-NTA) affinity chromatography according to the manufacturer's instructions (QIAGEN). The purified hexaHis-leptin was dialysed against 20 mM Tris-HCl, 500 mM NaCl, 8 M urea, pH 8·5, and then diluted dropwise to a final protein concentration of 50 µg/ml into 20 mM Tris-HCl, 500 mM NaCl, 2 M urea, pH 8·0. The protein was allowed to refold in this buffer for 18 h at 4 C and afterwards dialysed into 40 mM Tris-HCl, 140 mM NaCl, pH 8·0. The authenticity of the purified hexaHisleptin was verified by its relative size on SDS-PAGE and amino-terminal amino acid sequencing using an Applied Biosystems 471A protein sequencer (Foster City, CA, USA).
Tissue extracts
Fresh subcutaneous and internal visceral fat and muscle tissue was collected from two euthanased ewes and stored at -20 C. The tissues were homogenised in phosphate buffered saline (PBS), pH 7·5, containing 10 mM benzamidine (Sigma Chemical Company, St Louis, MO, USA) and 10 mM EDTA. The homogenate was then centrifuged at 10 000 g using a Sorval SS-34 fixed angle rotor (Dupont Medical Products, Newtown, CT, USA) for 30 min at 4 C. The supernatant was retained and concentrated 10 times using an Amicon stirred cell concentrator (Amicon, Beverly, MA, USA) and a PM10 (Amicon) membrane. The protein content of the extracts was then determined using the Bio-Rad DC protein kit (Bio-Rad Laboratories, Hercules, CA, USA) with bovine immunoglobulin (Ig) G as the standard. The concentrate was stored at -20 C until analysed.
Antibodies
Antibodies were raised in female chickens, which were immunised with 200 nM peptide conjugated to diphtheria toxoid or with 100 µg recombinant bovine leptin. Blood was initially collected to assess titres, followed by eggs when suitable titres had been achieved. IgY was isolated from the egg yolk of preimmune and immune chickens using a combination of caprylic acid and ammonium sulphate precipitation as previously described by McKinney & Parkinson (1987) . Three antibody preparations were used in this study, #JMCK4 raised against the carboxyl terminus, #JMCK13 raised against the amino terminus and #JMCK16 raised against bovine recombinant leptin (brLeptin).
Antisera and purified IgY were screened using an indirect enzyme-linked immunoabsorbent assay (ELISA) technique as described below. Approximately equivalent molar concentrations of peptides (9 ng/well) and brLeptin (100 ng/well) were coated onto the bottom of a flat bottomed ELISA plate (Greiner Labortechnik, Frickenhausen, Germany) in 50 µl 0·1 M bicarbonate, pH 9·0, buffer (binding buffer). Excess binding sites were blocked with 200 µl 5% skim milk in PBS for 1 h at 37 C. The plate was washed 5 times with 0·9% saline and 0·05% Triton-X 100, using a Titertek Microplate washer (Labsystems, Helsinki, Finland). Serial dilutions of antisera or purified IgY in PBS containing 3·3% Triton-X 100, 1·7% sodium deoxycholate and 0·17% sodium dodecyl sulphate (SDS) were added to the ELISA plate in a volume of 100 µl and incubated overnight at 37 C. The plate was washed and biotinylated rabbit anti-chicken IgY (Chemicon, Temecula, CA, USA) at a dilution of 1:10 000 in phosphate buffer, pH 8·0, containing 0·5 M sodium chloride, 0·5% Tween-20 and 0·1% BSA (ELISA buffer) was added to each well and incubated at 37 C for 1 h. The plate was washed and streptavidin conjugated to alkaline phosphatase (Amrad Biotech, Boronia, Vic, Australia) at a dilution of 1:5000 was incubated for 1 h at 37 C. The plate was developed with p-nitrophenylphosphate disodium salt hexahydrate (NPP) and read at 405 nm using a Titertek Multiskan Plus microplate reader (Labsystems).
Western blotting
Bovine recombinant leptin (1250 ng and 2500 ng), subcutaneous sheep fat extract and biotinylated broad range molecular size standards (Bio-Rad), were run on 12·5% SDS polyacrylamide reducing gels. Separated proteins were transferred to nitrocellulose membranes (0·22 µm, Schleicher and Schuell, Dassel, Germany) at 60 volts with cooling, in transfer buffer containing 20 mmol l -1 Tris base, 150 mmol l -1 glycine, 20% v/v methanol. At the conclusion of the transfer, the membranes were then blocked for 1 h with 3% non-fat dried milk in 20 mmol l -1
Tris-HCl, 0·15 mol l -1 NaCl buffer (TBS), pH 8. The membranes were then incubated with primary antiserum #JMCK16 or preimmune serum at a dilution of 1:250 in 1% non-fat dried milk in 20 mmol l -1 TBS for 24 h, then washed several times with 1% milk/TBS/0·1% Nonidet P-40 detergent (NP-40, Sigma). The second antiserum used for both membranes was a biotinylated rabbit antichicken IgY (Chemicon) at a dilution of 1:4000 in 1% milk/TBS/0·1% NP-40 for 24 h, followed by several washes as above and enhancement by avidin alkaline phosphatase conjugate (Pierce, Rockford, IL, USA) at a dilution of 1:1000. The membranes were then developed with NBT/BCIP One-Step (Pierce).
Leptin assays
A competitive ELISA was developed using #JMCK16 which was biotinylated using NHS-LC-Biotin (Pierce). The ELISA plate was coated with 6 ng brLeptin in 50 µl 0·1 M bicarbonate buffer, pH 9·0, (binding buffer) overnight at 37 C. The plate was blocked with 200 µl 5% skim milk in ELISA buffer for 1 h at 37 C. The sample was added to the well in a volume of 100 µl and the antiserum in a volume of 50 µl 10% Triton-X 100, 0·5% SDS and 5% sodium deoxycholate, and the plate was incubated overnight at 37 C. Streptavidin conjugated to alkaline phosphatase (Amrad Biotech) was incubated for 1 h and the plate developed with NPP. The plate was washed 5 times between each step with a washing buffer containing 0·9% saline and 0·05% Triton-X 100, using a Titertek Microplate washer.
The cross-reactivity of recombinant human (R&D Systems, Minneapolis, MN, USA) and mouse (Insight Biotechnology, Wembley, Middlesex, UK) leptin was determined in the assay using doses of up to 100 ng/ml. The specificity of the assay was assessed using the following non-specific proteins serially diluted from 10 µg/ml, ovine luteinising hormone (NIDDK, Bethesda, MD, USA), ovine albumin (Sigma), human recombinant follistatin (NIDDK), insulin (Aza Research, West Ryde, NSW, Australia) and equine chorionic gonadotrophin (Horizon Pty Ltd, North Ryde, NSW, Australia).
Recoveries of leptin from plasma were determined by adding 5, 10 and 20 ng brLeptin per ml of pooled ewe or wether plasma. All samples were assayed in duplicate with 3 dilutions (neat, ½, ¼) using ELISA buffer as diluent. Pools of plasma from adult ewes, rams and castrate males (wethers) were used to determine the degree of parallelism in the assay. Individual plasma samples from 4 ewes, 5 wethers and 4 rams were assayed to determine the mean leptin concentrations in plasma from different sexes.
Experimental treatments
Adult merino wethers were housed individually in small pens for 24 h before treatment and starved overnight. Insulin (1 iu/kg), adrenaline (65 µg/kg) and glucagon (1 mg/kg) were administered intravenously to groups of 3-4 sheep and blood samples were taken from a jugular catheter at 0, 1, 3, 5, 10, 20, 30, 60, 90 and 120 min after the injection of hormone. A single bolus dose of glucose (240 mg/kg) was given intravenously and blood samples taken at 0, 15, 30, 45, 60, 120 min post injection. Blood was collected into heparinised tubes and plasma stored at -20 C until assayed.
Data analysis
Parallel-line statistics (Finney 1978) and one-way analysis of variance followed by a Student-Newman-Keuls multiple range test were performed using the SAS computer software package (SAS Institute Inc., Cary, NC, USA). Concentration of leptin in samples was determined using a four parameter logistic curve fitting algorithm option in the Genesis software package (Life Sciences International UK, Basingstoke, Hants, UK). These experiments were approved by the University of New England Animal Ethics Committee and conform to the NHMRC/CSIRO/AAC Code of Practice for the Care and Use of Animals for Experimental Purposes.
Results
Antibodies were successfully raised against recombinant leptin and the peptides as shown in Fig. 1 . Interestingly, the antibodies to the terminal peptides showed very little cross-reactivity with the brLeptin, while antibodies to brLeptin had a poor cross-reactivity to either of the terminal peptides. These data indicate that although antibodies were successfully raised against the amino and carboxyl terminus of the bovine leptin molecule, these antibodies had a poor cross-reactivity with the intact molecule. Consequently, JMCK#16 was used to develop the leptin ELISA as described below. The epitope recognised by this antibody remains to be determined.
Western blot analysis with a long period of development showed that the brLeptin migrated at 16·7 kDa ( Fig. 2A,  lanes 1 and 2) and that a specific equivalent band (Fig. 2A , lane 3) could be observed in the fat extract. The preimmune antibodies did not recognise the recombinant leptin (Fig. 2B, lanes 4 and 5) or the putative native leptin (Fig. 2B, lane 6 ) recognised by the immune serum. Two other bands were observed at 14 kDa and 32 kDa (Fig. 2A , lane 3) which were not present on the preimmune blot (Fig. 2B, lane 6) .
The competitive ELISA had a standard curve ranging from 100 ng to 0·2 ng/ml with a sensitivity of approximately 0·5 ng/ml. The inter-and intra-assay variation is 15% and 7% respectively. There was no interference or cross-reactivity in the assay by any of the non-specific proteins at doses up to 10 µg/ml. The dilution curve from a pool of ewe plasma was linear and parallel to the standard curve, as shown in Fig. 3A , as were the pools of ram and wether plasma. The aqueous extract from subcutaneous fat also diluted in a linear fashion parallel to the brLeptin standard curve (Fig. 3A) . Immunoactive leptin was detected in extracts from internal fat and muscle tissue, with concentrations of 103 pg/mg and 2·4 pg/mg of protein respectively. This was much less than that detected in the extract from subcutaneous fat (623 pg/mg). The crossreactivity of recombinant human leptin (Fig. 3B) and mouse leptin was 36·5% and >1% respectively. Recovery of brLeptin from spiked samples of pooled ewe plasma was 95% 3%. The mean ( ..) leptin concentrations in plasma samples were 6·0 2·9 ng/ml from ewes (n=4), Figure 1 The relative cross-reactivity of antibodies raised against equivalent molar concentrations of the carboxyl (C-Terminus) and amino (N-Terminus) terminal leptin peptides and rbLeptin in an indirect ELISA to the 3 different antigens.
Figure 2
Western blot analysis of brLeptin (lanes 1, 2, 4 and 5) and a subcutaneous fat extract (lanes 3 and 6) using immune (A) and preimmune (B) antibodies from chicken JMCK#16. STD=mw standards 3·3 0·4 ng/ml from wethers (n=5) and 3·1 1·3 ng/ml from rams (n=4).
The mean leptin and glucose levels from the experimental sheep receiving a bolus intravenous dose of 1 iu/kg insulin are shown in Fig. 4 . The single injection of insulin induced a significant (P<0·05) decrease in plasma glucose, from 63 mg/dl to 24 mg/dl at 50 min following injection. Glucose levels remained depressed at the conclusion of blood sampling at 120 min. As shown in Fig. 4 , no significant change (P=0·5) in leptin levels occurred for the duration of the experiment.
An intravenous injection of adrenaline stimulated a significant (P<0·01) rise in blood glucose from 67 mg/dl to 167 mg/dl within 10 min (Fig. 5) , which remained elevated until near the end of the experiment when it began to decline. Leptin levels (at approximately 4 ng/ml) did not change significantly (P=0·95) throughout the experimental period.
Glucagon stimulated a significant (P<0·001) rise in blood glucose after the intravenous injection (Fig. 6 ). Blood glucose levels rose from 63 mg/dl to a maximum of 184 mg/dl at 30 min following the injection and began to decline by 120 min. No significant change (P=0·75) in the concentration of leptin was observed during the sampling period.
In the last experiment, a bolus intravenous injection of glucose significantly (P<0·001) raised blood glucose from 72 mg/dl (data not shown) to 207 mg/dl at 15 min post injection followed by a steady decline to normal levels by 180 min as shown in Fig. 7 . Leptin levels remained unchanged (P=0·92) throughout the experimental period at approximately 3·5 ng/ml.
The glucose levels and leptin levels in the control sheep which were given an injection of vehicle (saline) showed no significant change (P=0·9, P=0·9 respectively) throughout the period of blood sampling (data not shown).
Discussion
A number of immunoassays for leptin have been described since its recent discovery and the cloning of the gene (Zhang et al. 1994) . These assays have used antiserum raised against the amino (McGregor et al. 1996) or carboxyl (Horn et al. 1996) terminus of the hormone or the whole protein (Considine et al. 1996) . In this study, we used similar peptides derived from the bovine leptin cDNA sequence (Genbank U50365) and brLeptin to raise antibodies. We were able successfully to raise antibodies with suitable titres to both peptides and to the recombinant protein; however, there was very little crossreactivity with the antisera raised against peptides to the recombinant molecule. This was an unexpected result since we had used peptide sequences very similar to those used by others (Horn et al. 1996 , McGregor et al. 1996 . These data suggest that these peptides are not readily accessible in the intact molecule and that other regions of the molecule should be explored for suitable epitopes to raise specific antisera to leptin of other species.
Using the antisera raised against recombinant bovine leptin, we successfully developed a specific competitive ELISA for bovine leptin. Ovine leptin has a 99% homology to bovine leptin (Dyer et al. 1997) so it is likely that ovine leptin would have close to 100% cross-reactivity in the assay. Western blot analysis detects a specific immunoactive band at 16 kDa which strongly suggests that the antibodies recognise native ovine leptin. Two other bands were also detected which may represent degraded and aggregated molecules or alternatively they may be related molecules. Further studies are required to determine the nature of these other proteins. Dose-response curves of immunoactive leptin in plasma and fat extracts were linear and parallel to the brLeptin standard curve, and the quantitative recovery of recombinant leptin from spiked plasma samples suggest that the assay reported here is measuring ovine leptin. Our data indicate that subcutaneous fat extracts contain more leptin protein than internal fat, supporting results from several human studies showing that the expression of leptin mRNA is higher in subcutaneous than omental fat (Montague et al. 1997) .
Several different molecular weight species of leptinbinding proteins have been identified in both human and mouse serum (Houseknecht et al. 1996 , Gavrilova et al. 1997 . One of these has been isolated, and after amino acid sequencing it was shown to be a form of the leptin receptor (Gavrilova et al. 1997) . The plasma concentration of this soluble form of the receptor, which increases during pregnancy in mice, was reported as interfering in leptin assays (Gavrilova et al. 1997) . The leptin assay reported here has included reagents previously shown to dissociate follistatin (an activin binding protein) from activin, allowing the assay of activin in the presence of follistatin (McFarlane et al. 1996) . The presence of these reagents in the assay would suggest that binding proteins do not interfere with this assay, although we have yet formally to demonstrate this.
The plasma leptin levels in ewes were significantly higher (P<0·05) than those in ram or wether plasma, as has been reported previously in humans and in rodents (Watanobe & Suda 1999) . However, no significant difference in leptin concentrations was observed between ram and wether plasma. This would suggest that the lower plasma leptin concentrations seen in ram plasma are not due to testosterone as has been suggested in humans (Rosenbaum et al. 1996 , Jockenhovel et al. 1997 , Roemmich et al. 1998 . There is some evidence that oestradiol increases leptin production in adipose tissue (Casabiell et al. 1998) and in the plasma of transsexual men treated with oestradiol together with an androgen antagonist (Elbers et al. 1997) . These studies, together with the data presented here, suggest that the higher leptin levels in ewe plasma may be due to oestrogen rather than that the lower levels seen in rams are due to testosterone. However, further work is required to confirm this hypothesis and we are currently investigating this possibility.
Using this assay, we investigated the effect of blood glucose and various regulators of blood glucose on leptin concentrations in the sheep. These preliminary results indicate that glucose is not an important short-term regulator of plasma leptin levels in sheep and consequently hormones that affect blood glucose do not influence leptin levels. In this respect, sheep and humans are similar and contrast with mice where insulin directly influences adipocytes to secrete leptin both in vitro (Leroy et al. 1996) and in vivo (Saladin et al. 1995) . The fact that leptin levels in sheep do not seem to respond to changes in blood glucose concentration is not surprising as ruminants derive the majority of their energy from bacterial fermentation products in the form of fatty acids. Therefore, it remains possible that plasma leptin levels may be modulated by fatty acids.
In the sheep, plasma leptin levels may be involved in signalling body fat/nutrient stores rather than in modulating short-term changes in blood glucose levels, when leptin concentration appears to be static. Ball et al. (1998) observed differences between sheep in the pattern of conservation of body tissue during feed restriction, with mobilization of fat being the most variable. If leptin is involved in changes of energy expenditure in the sheep, variation in leptin concentration may be associated with differences in an animal's ability to cope with nutritional stress. This possible link between leptin concentration and nutritional stress in sheep remains to be explored.
